content: <!-- CoverPageHeader start -->
  <!DOCTYPE html PUBLIC "-//W3C//DTD HTML 3.2//EN">
  <HTML>
  <HEAD>
  <TITLE> MedAire, Inc. (Form: 8-K) </TITLE>
  </HEAD>
  <BODY TEXT="#000000" BGCOLOR="#FFFFFF" ALINK="#0000FF" HLINK="#FF0000" VLINK="#800080">
  <A NAME="DOCUMENT_TOP">&nbsp;</A>
  <P>
  <!-- CoverPageHeader end --><!-- CoverPageTitle START -->
  <A NAME="DOCUMENT_TOP">&nbsp;</A>
  <HR NOSHADE>
  <P>
  <P ALIGN="CENTER">
  <FONT SIZE="4">
  		UNITED STATES<BR>
  	SECURITIES AND EXCHANGE COMMISSION
  </FONT>
  <BR>
  <FONT SIZE="2">
  	WASHINGTON, D.C. 20549
  </FONT>
  <P ALIGN="CENTER">
  <FONT SIZE="5">
  	FORM 8-K
  </FONT>
  <FONT SIZE="2">
  
  </FONT>
  </P>
  <P ALIGN="CENTER">
  <FONT SIZE="3">
  	CURRENT REPORT
  </FONT>
  </P>
  <P ALIGN="CENTER">
  <FONT SIZE="2">
  	Pursuant to Section&nbsp;13 or 15(d) of the Securities Exchange Act of 1934
  </FONT>
  </P>
  <CENTER>
  <TABLE CELLSPACING="0" BORDER="0" CELLPADDING="0" WIDTH="100%">
  <TR VALIGN="BOTTOM">
  <TD WIDTH="51%">
  	&nbsp;
  </TD>
  <TD WIDTH="5%">
  	&nbsp;
  </TD>
  <TD WIDTH="44%">
  	&nbsp;
  </TD>
  </TR>
  <TR VALIGN="BOTTOM">
  <TD ALIGN="CENTER" VALIGN="TOP">
  <FONT SIZE="2">
  	Date of Report (Date of Earliest Event Reported):
  </FONT>
  </TD>
  <TD>
  <FONT SIZE="2">
  	&nbsp;
  </FONT>
  </TD>
  <TD ALIGN="CENTER" VALIGN="TOP">
  <FONT SIZE="2">
  	March 8, 2006
  </FONT>
  </TD>
  </TR>
  </TABLE>
  <BR>
  </CENTER>
  <!-- CoverPageTitle END --><!-- CoverPageRegistrant START -->
  <P ALIGN="CENTER"><!-- -->
  <FONT SIZE="6">
  	MedAire, Inc.
  </FONT>
  <FONT SIZE="2">
  <BR>__________________________________________<BR>
  	(Exact name of registrant as specified in its charter)
  </FONT>
  <CENTER>
  <TABLE CELLSPACING="0" BORDER="0" CELLPADDING="0" WIDTH="100%">
  <TR VALIGN="BOTTOM">
  <TD WIDTH="33%">
  	&nbsp;
  </TD>
  <TD WIDTH="34%">
  	&nbsp;
  </TD>
  <TD WIDTH="33%">
  	&nbsp;
  </TD>
  </TR>
  <TR VALIGN="BOTTOM">
  <TD ALIGN="CENTER" VALIGN="TOP">
  <FONT SIZE="2">
  	Nevada
  </FONT>
  </TD>
  <TD ALIGN="CENTER" VALIGN="TOP">
  <FONT SIZE="2">
  	C025328-02
  </FONT>
  </TD>
  <TD ALIGN="CENTER" VALIGN="TOP">
  <FONT SIZE="2">
  	86-0528631
  </FONT>
  </TD>
  </TR>
  <TR VALIGN="BOTTOM">
  <TD ALIGN="CENTER" VALIGN="TOP">
  <FONT SIZE="2">
  _____________________<BR>
  	(State or other jurisdiction
  </FONT>
  </TD>
  <TD ALIGN="CENTER" VALIGN="TOP">
  <FONT SIZE="2">
  _____________<BR>
  	(Commission
  </FONT>
  </TD>
  <TD ALIGN="CENTER" VALIGN="TOP">
  <FONT SIZE="2">
  ______________<BR>
  	(I.R.S. Employer
  </FONT>
  </TD>
  </TR>
  <TR VALIGN="BOTTOM">
  <TD ALIGN="CENTER" VALIGN="TOP">
  <FONT SIZE="2">
  	of incorporation)
  </FONT>
  </TD>
  <TD ALIGN="CENTER" VALIGN="TOP">
  <FONT SIZE="2">
  	File Number)
  </FONT>
  </TD>
  <TD ALIGN="CENTER" VALIGN="TOP">
  <FONT SIZE="2">
  	Identification No.)
  </FONT>
  </TD>
  </TR>
  <TR VALIGN="BOTTOM">
  <TD ALIGN="CENTER" VALIGN="TOP">
  <FONT SIZE="2">
  	&nbsp;&nbsp;
  </FONT>
  </TD>
  <TD ALIGN="CENTER" VALIGN="TOP">
  <FONT SIZE="2">
  	&nbsp;
  </FONT>
  </TD>
  <TD ALIGN="CENTER" VALIGN="TOP">
  <FONT SIZE="2">
  	&nbsp;
  </FONT>
  </TD>
  </TR>
  <TR VALIGN="BOTTOM">
  <TD ALIGN="CENTER" VALIGN="TOP">
  <FONT SIZE="2">
  	80 E. Rio Salado Parkway, Suite 610, Tempe, Arizona
  </FONT>
  </TD>
  <TD ALIGN="CENTER" VALIGN="TOP">
  <FONT SIZE="2">
  	&nbsp;
  </FONT>
  </TD>
  <TD ALIGN="CENTER" VALIGN="TOP">
  <FONT SIZE="2">
  	85281
  </FONT>
  </TD>
  </TR>
  <TR VALIGN="BOTTOM">
  <TD ALIGN="CENTER" VALIGN="TOP">
  <FONT SIZE="2">
  _________________________________<BR>
  	(Address of principal executive offices)
  </FONT>
  </TD>
  <TD ALIGN="CENTER" VALIGN="TOP">
  <FONT SIZE="2">
  	&nbsp;
  </FONT>
  </TD>
  <TD ALIGN="CENTER" VALIGN="TOP">
  <FONT SIZE="2">
  ___________<BR>
  	(Zip Code)
  </FONT>
  </TD>
  </TR>
  </TABLE>
  </CENTER>
  <CENTER>
  <TABLE CELLSPACING="0" BORDER="0" CELLPADDING="0" WIDTH="100%">
  
  <TR VALIGN="BOTTOM">
  <TD WIDTH="51%">
  	&nbsp;
  </TD>
  <TD WIDTH="5%">
  	&nbsp;
  </TD>
  <TD WIDTH="44%">
  	&nbsp;
  </TD>
  </TR>
  <TR VALIGN="BOTTOM">
  <TD ALIGN="CENTER" VALIGN="TOP">
  <FONT SIZE="2">
  	Registrant&#146;s telephone number, including area code:
  </FONT>
  </TD>
  <TD>
  <FONT SIZE="2">
  	&nbsp;
  </FONT>
  </TD>
  <TD ALIGN="CENTER" VALIGN="TOP">
  <FONT SIZE="2">
  	480-333-3764
  </FONT>
  </TD>
  </TR>
  </TABLE>
  </CENTER>
  <P ALIGN="CENTER">
  <FONT SIZE="2">
  	Not Applicable
  <BR>______________________________________________<BR>
  	Former name or former address, if changed since last report
  </FONT>
  <P ALIGN="CENTER">
  <FONT SIZE="2">
  	&nbsp;
  </FONT>
  <!-- CoverPageRegistrant END --><P><FONT SIZE="2">
  Check the appropriate box below if the Form 8-K filing is intended to
  simultaneously satisfy the filing obligation of the registrant under any
  of the following provisions:</FONT>
  </P>
  <P><FONT SIZE="2">
  [&nbsp;&nbsp;]&nbsp;&nbsp;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)<br>
  [&nbsp;&nbsp;]&nbsp;&nbsp;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)<br>
  [&nbsp;&nbsp;]&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))<br>
  [&nbsp;&nbsp;]&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))<br>
  </P></FONT><!-- PageBreak START -->
  <P>
  <HR NOSHADE>
  <DIV ALIGN="LEFT" STYLE="PAGE-BREAK-BEFORE:ALWAYS">
  <A HREF="#DOCUMENT_TOP">
  <U>
  <B>
  <FONT SIZE="2">Top of the Form</FONT>
  </B>
  </U>
  </A>
  </DIV>
  <!-- PageBreak END --><!-- Item START -->
  <P ALIGN="LEFT">
  <FONT SIZE="2">
  <B>
  	Item 1.01 Entry into a Material Definitive Agreement.
  </B>
  </FONT>
  </P>
  <P ALIGN="LEFT">
  <FONT SIZE="2">
  On March 8, 2006, the Company entered into employment agreements with Joan Sullivan Garrett to transition from Chief Executive Officer to Chairman, James E. Lara to continue acting as President and Chief Operating Officer, and James Allen Williams to take over as Chief Executive Officer.<br><br>The Garrett Employment Agreement generally provides that Ms. Garrett will act as Chairman of the Company and be responsible for the representation and promotion of MedAire's brand to customers, governmental authorities, the medical community, and other stakeholders.  Ms. Garrett will further assist in formulating the strategic vision of the Company, but will not have any day-to-day management responsibility.  Ms. Garrett will retain all of the benefits and perquisites under her previous employment agreement, including an annual base salary of $249,690, an automobile allowance of $950 per month, and participation in the Company&#x2019;s benefit plans, including bonus, medical, dental and vision insurance, life insurance, long term disability insurance and the 401(k) plan.  The Garrett Employment Agreement will have a term of five years and will provide that Ms. Garrett's employment may not be terminated under any circumstances, but that the board of directors can elect to put Ms. Garrett on garden leave for the duration of the term of her employment, during which leave she will continue to be entitled to all pay, benefits and perquisites.  The Garrett Employment Agreement includes non-competition provisions which will end when the term of Ms. Garrett's employment ends.<br><br>The Lara Employment Agreement generally provides that Mr. Lara will act as President and Chief Operating Officer of the Company.  Mr. Lara will retain all of the benefits and perquisites under his previous employment agreement, including an annual base salary of $216,300, an automobile allowance of $500 per month, and participation in the Company&#x2019;s benefit plans, including medical, dental and vision insurance, life insurance, long term disability insurance and the 401(k) plan.  The term of the Lara Employment Agreement runs through December 31, 2007 and is renewed automatically for additional one year periods, unless either party serves written notice of an intent not to renew at least six months before the end of the initial or any renewal term.  The Lara Employment Agreement may not be terminated under any circumstances, but the board of directors can elect, at any time, to place Mr. Lara on garden leave for 12 months with full pay, benefits and perquisites.  The Lara Employment Agreement includes non-competition provisions which will end two years after Mr. Lara's employment ends and confidentiality provisions that continue indefinitely.<br><br>The Williams Employment Agreement generally provides that Mr. Williams will act as Chief Executive Officer of the Company and receive an annual base salary of $243,500, an automobile allowance of $500 per month, and participation in the Company&#x2019;s benefit plans, including medical, dental and vision insurance, life insurance, long term disability insurance and the 401(k) plan.  The term of the Williams Employment Agreement runs through December 31, 2007 and is renewed automatically for additional one year periods, unless either party serves written notice of an intent not to renew at least six months before the end of the initial or any renewal term.  The Williams Employment Agreement also includes a provision entitling the Company, at any time, to place Mr. Williams on garden leave for 12 months with full pay, benefits and perquisites.  The Williams Employment Agreement includes non-competition provisions which will end two years after Mr. Williams' employment ends and confidentiality provisions that continue indefinitely.
  </FONT>
  </P>
  <!-- Item END -->
  <BR><BR><BR><BR><!-- Item START -->
  <P ALIGN="LEFT">
  <FONT SIZE="2">
  <B>
  	Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.
  </B>
  </FONT>
  </P>
  <P ALIGN="LEFT">
  <FONT SIZE="2">
  As previously disclosed, actions set forth in Consent Resolutions executed by shareholders holding the requisite number of outstanding shares of the voting stock of the Company necessary to approve such actions, which were included in a definitive Information Statement on Schedule 14C filed with the SEC and mailed to all shareholders of record on February 9, 2006, became effective March 1, 2006, 20 days from the date of such mailing. <br><br>On March 8, 2006, the new Board of Directors of the Company elected pursuant to such Consent Resolutions held its first meeting,  received Joan Sullivan Garrett's resignation as Chief Executive Officer, designated Ms. Garrett to continue as Chairman of the Board pursuant to a new employment agreement, the terms of which are discussed under Item 1.01 above and incorporated by reference herein, and designated James Allen Williams to replace Ms. Garrett as Chief Executive Officer pursuant to a new employment agreement, the terms of which are discussed under Item 1.01 above and are incorporated by reference herein.  <br><br>Mr. Williams will continue as a member of the Company's Board of Directors, a position he has held since December 21, 2005.  Mr. Williams served as Executive Vice President and General Manager of International SOS Assistance, Inc. ("International SOS"), an emergency medical assistance company, from March 1999 through December 2004.  From December 2004 through October 2005, Mr. Williams served as President and Chief Operating Officer, Americas Region, of International SOS.  From October 2005 through December 2005, Mr. Williams served as Group Director for Health and Safety Market Development for International SOS.  Mr. Williams' corporate responsibilities for International SOS have included the consolidation of United States International SOS operations, building a professional management team, direct oversight of International SOS' operations in North, Central and South America and development of health and safety commercial strategy and capabilities for the oil and gas industries and the commercial and military aviation sectors.  Mr. Williams earned his Bachelor of Science degree in Mechanical Engineering from North Carolina State University.  Mr. Williams' business address is c/o International SOS Assistance Inc., 3600 Horizon Blvd., Suite 300, Trevose, Pennsylvania, 19053.
  </FONT>
  </P>
  <!-- Item END -->
  <BR><BR><BR><BR><!-- Item START -->
  <P ALIGN="LEFT">
  <FONT SIZE="2">
  <B>
  	Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
  </B>
  </FONT>
  </P>
  <P ALIGN="LEFT">
  <FONT SIZE="2">
  As previously disclosed, actions set forth in Consent Resolutions executed by shareholders holding the requisite number of outstanding shares of the voting stock of the Company necessary to approve such actions, which were included in a definitive Information Statement on Schedule 14C filed with the SEC and mailed to all shareholders of record on February 9, 2006, became effective March 1, 2006, 20 days from the date of such mailing. <br><br>The Consent Resolutions included a shareholder resolution asking the Board of Directors to consider amending Section 2 of Article II of the Company's Amended and Restated Bylaws to allow shareholders holding at least 10% of the Company's outstanding voting stock to call a special meeting of the shareholders (the "Bylaw Amendment").  At its meeting held on March 8, 2006, the Board of Directors considered and approved the Bylaw Amendment in the form attached hereto as Exhibit 99.1.  Prior to effectiveness of the Bylaw Amendment, shareholders did not have the right to call a special meeting of the shareholders.
  </FONT>
  </P>
  <!-- Item END -->
  <BR><BR><BR><BR><!-- Item START -->
  <P ALIGN="LEFT">
  <FONT SIZE="2">
  <B>
  	Item 8.01 Other Events.
  </B>
  </FONT>
  </P>
  <P ALIGN="LEFT">
  <FONT SIZE="2">
  On March 10, 2006, the Company issued the press release attached hereto as Exhibit 99.2 and incorporated by reference herein summarizing the events described in this report.
  </FONT>
  </P>
  <!-- Item END -->
  <BR><BR><BR><BR><!-- Item START -->
  <P ALIGN="LEFT">
  <FONT SIZE="2">
  <B>
  	Item 9.01 Financial Statements and Exhibits.
  </B>
  </FONT>
  </P>
  <P ALIGN="LEFT">
  <FONT SIZE="2">
  99.1  Bylaw Amendment Dated March 8, 2006<br>99.2  Press Release Dated March 10, 2006 <br>
  </FONT>
  </P>
  <!-- Item END -->
  <BR><BR><BR><BR><P ALIGN="LEFT" STYLE="FONT-SIZE: 10PT"></P><!-- PageBreak START -->
  <P>
  <HR NOSHADE>
  <DIV ALIGN="LEFT" STYLE="PAGE-BREAK-BEFORE:ALWAYS">
  <A HREF="#DOCUMENT_TOP">
  <U>
  <B>
  <FONT SIZE="2">Top of the Form</FONT>
  </B>
  </U>
  </A>
  </DIV>
  <!-- PageBreak END --><!-- SignatureHeader START -->
  <P ALIGN="CENTER">
  <FONT SIZE="2">
  <B>
  	SIGNATURES
  </B>
  </FONT>
  </P>
  <P ALIGN="LEFT">
  <FONT SIZE="2">
  	Pursuant to the requirements of the Securities Exchange Act of 1934, the
  	registrant has duly caused this report to be signed on its behalf by the
  	undersigned hereunto duly authorized.
  </FONT>
  </P>
  <!-- SignatureHeader END --><!-- Signature START -->
  <CENTER>
  <TABLE CELLSPACING="0" BORDER="0" CELLPADDING="0" WIDTH="100%">
  <TR VALIGN="BOTTOM">
  <TD WIDTH="19%">
  	&nbsp;
  </TD>
  <TD WIDTH="34%">
  	&nbsp;
  </TD>
  <TD WIDTH="3%">
  	&nbsp;
  </TD>
  <TD WIDTH="1%">
  	&nbsp;
  </TD>
  <TD WIDTH="43%">
  	&nbsp;
  </TD>
  </TR>
  <TR VALIGN="BOTTOM">
  <TD VALIGN="TOP">
  <FONT SIZE="2">
  	&nbsp;
  </FONT>
  </TD>
  <TD>
  <FONT SIZE="2">
  	&nbsp;
  </FONT>
  </TD>
  <TD COLSPAN="3" VALIGN="TOP" ALIGN="LEFT">
  <FONT SIZE="2">
  	MedAire, Inc.
  </FONT>
  </TD>
  </TR>
  <TR VALIGN="BOTTOM">
  <TD VALIGN="TOP">
  <FONT SIZE="2">
  	&nbsp;&nbsp;
  </FONT>
  </TD>
  <TD>
  <FONT SIZE="2">
  	&nbsp;
  </FONT>
  </TD>
  <TD ALIGN="LEFT" VALIGN="TOP">
  <FONT SIZE="2">
  	&nbsp;
  </FONT>
  </TD>
  <TD>
  <FONT SIZE="2">
  	&nbsp;
  </FONT>
  </TD>
  <TD ALIGN="LEFT" VALIGN="TOP">
  <FONT SIZE="2">
  	&nbsp;
  </FONT>
  </TD>
  </TR>
  <TR VALIGN="BOTTOM">
  <TD VALIGN="TOP">
  <FONT SIZE="2">
  <I>
  	March 10, 2006
  </I>
  </FONT>
  </TD>
  <TD>
  <FONT SIZE="2">
  	&nbsp;
  </FONT>
  </TD>
  <TD ALIGN="LEFT" VALIGN="TOP">
  <FONT SIZE="2">
  <I>
  	By:
  </I>
  </FONT>
  </TD>
  <TD>
  <FONT SIZE="2">
  	&nbsp;
  </FONT>
  </TD>
  <TD ALIGN="LEFT" VALIGN="TOP">
  <FONT SIZE="2">
  <I>
  	James Allen Williams
  </I>
  <BR>
  </FONT>
  </TD>
  </TR>
  <TR>
  <TD VALIGN="TOP">
  <FONT SIZE="2">
  	&nbsp;
  </FONT>
  </TD>
  <TD>
  <FONT SIZE="2">
  	&nbsp;
  </FONT>
  </TD>
  <TD ALIGN="LEFT" VALIGN="TOP">
  <FONT SIZE="2">
  	&nbsp;
  </FONT>
  </TD>
  <TD>
  <FONT SIZE="2">
  	&nbsp;
  </FONT>
  </TD>
  <TD ALIGN="LEFT" VALIGN="TOP">
  <HR SIZE="1" NOSHADE>
  </TD>
  </TR>
  <TR VALIGN="BOTTOM">
  <TD VALIGN="TOP">
  <FONT SIZE="2">
  	&nbsp;
  </FONT>
  </TD>
  <TD>
  <FONT SIZE="2">
  	&nbsp;
  </FONT>
  </TD>
  <TD ALIGN="LEFT" VALIGN="TOP">
  <FONT SIZE="2">
  	&nbsp;
  </FONT>
  </TD>
  <TD>
  <FONT SIZE="2">
  	&nbsp;
  </FONT>
  </TD>
  <TD ALIGN="LEFT" VALIGN="TOP">
  <FONT SIZE="2">
  <I>
  	Name: James Allen Williams
  </I>
  </FONT>
  </TD>
  </TR>
  <TR VALIGN="BOTTOM">
  <TD VALIGN="TOP">
  <FONT SIZE="2">
  	&nbsp;
  </FONT>
  </TD>
  <TD>
  <FONT SIZE="2">
  	&nbsp;
  </FONT>
  </TD>
  <TD ALIGN="LEFT" VALIGN="TOP">
  <FONT SIZE="2">
  	&nbsp;
  </FONT>
  </TD>
  <TD>
  <FONT SIZE="2">
  	&nbsp;
  </FONT>
  </TD>
  <TD ALIGN="LEFT" VALIGN="TOP">
  <FONT SIZE="2">
  <I>
  	Title: CEO
  </I>
  </FONT>
  </TD>
  </TR>
  </TABLE>
  </CENTER>
  <!-- Signature END --><!-- PageBreak START -->
  <P>
  <HR NOSHADE>
  <DIV ALIGN="LEFT" STYLE="PAGE-BREAK-BEFORE:ALWAYS">
  <A HREF="#DOCUMENT_TOP">
  <U>
  <B>
  <FONT SIZE="2">Top of the Form</FONT>
  </B>
  </U>
  </A>
  </DIV>
  <!-- PageBreak END --><P ALIGN="CENTER">
  <FONT SIZE="2">
  	Exhibit&nbsp;Index
  </FONT>
  <CENTER>
  <TABLE CELLSPACING="0" BORDER="0" CELLPADDING="0" WIDTH="60%">
  <TR VALIGN="BOTTOM">
  <TD WIDTH="8%">
  	&nbsp;
  </TD>
  <TD WIDTH="15%">
  	&nbsp;
  </TD>
  <TD WIDTH="77%">
  	&nbsp;
  </TD>
  </TR>
  
  <BR>
  <TR VALIGN="BOTTOM">
  <TD NOWRAP ALIGN="LEFT">
  <FONT SIZE="1">
  <B>
  	Exhibit No.
  </B>
  </FONT>
  </TD>
  <TD>
  <FONT SIZE="1">
  	&nbsp;
  </FONT>
  </TD>
  <TD NOWRAP ALIGN="LEFT">
  <FONT SIZE="1">
  <B>
  	Description
  </B>
  </FONT>
  </TD>
  </TR>
  <TR VALIGN="BOTTOM">
  <TD NOWRAP ALIGN="CENTER">
  <HR SIZE="1" NOSHADE>
  </TD>
  <TD>
  <FONT SIZE="1">
  	&nbsp;
  </FONT>
  </TD>
  <TD NOWRAP ALIGN="CENTER">
  <HR ALIGN="LEFT" SIZE="1" WIDTH="88%" NOSHADE>
  </TD>
  </TR>
  
  
  
  
  
  <TR VALIGN="BOTTOM">
  <TD VALIGN="TOP" WIDTH="8%" nowrap>
  <FONT SIZE="2">
  <DIV ALIGN="LEFT">
  	99.1
  </DIV>
  </FONT>
  </TD>
  <TD WIDTH="15%">
  <FONT SIZE="2">
  	&nbsp;
  </FONT>
  </TD>
  <TD ALIGN="LEFT" VALIGN="TOP" WIDTH="77%">
  <FONT SIZE="2">
  Bylaw Amendment Dated March 8, 2006
  </FONT>
  </TD>
  </TR>
  <TR VALIGN="BOTTOM">
  <TD VALIGN="TOP" WIDTH="8%" nowrap>
  <FONT SIZE="2">
  <DIV ALIGN="LEFT">
  	99.2
  </DIV>
  </FONT>
  </TD>
  <TD WIDTH="15%">
  <FONT SIZE="2">
  	&nbsp;
  </FONT>
  </TD>
  <TD ALIGN="LEFT" VALIGN="TOP" WIDTH="77%">
  <FONT SIZE="2">
  Press Release Dated March 10, 2006
  </FONT>
  </TD>
  </TR></TABLE></CENTER><!-- HTMLFooter START -->
  </BODY>
  </HTML>
  <!-- HTMLFooter END -->
metadata_documents: [{"type": "8-K", "sequence": "1", "filename": "htm_10866.htm", "description": "LIVE FILING", "secsgml_size_bytes": 18078}]
metadata_filer: {"company-data": {"conformed-name": "MedAire, Inc.", "cik": "0001337301", "assigned-sic": "8742", "irs-number": "860528631", "state-of-incorporation": "NV", "fiscal-year-end": "0308"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-51555", "film-number": "06678448"}, "business-address": {"street1": "80 E. RIO SALADO PARKWAY", "street2": "SUITE 610", "city": "TEMPE", "state": "AZ", "zip": "85281", "phone": "480-333-3700"}, "mail-address": {"street1": "80 E. RIO SALADO PARKWAY", "street2": "SUITE 610", "city": "TEMPE", "state": "AZ", "zip": "85281"}}
text: MedAire, Inc. (Form: 8-K)
  UNITED STATES
  SECURITIES AND EXCHANGE COMMISSION
  WASHINGTON, D.C. 20549
  FORM 8-K
  CURRENT REPORT
  Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
  Date of Report (Date of Earliest Event Reported):
  March 8, 2006
  MedAire, Inc.
  __________________________________________
  (Exact name of registrant as specified in its charter)
  Nevada
  C025328-02
  86-0528631
  _____________________
  (State or other jurisdiction
  _____________
  (Commission
  ______________
  (I.R.S. Employer
  of incorporation)
  File Number)
  Identification No.)
  80 E. Rio Salado Parkway, Suite 610, Tempe, Arizona
  85281
  _________________________________
  (Address of principal executive offices)
  ___________
  (Zip Code)
  Registrant's telephone number, including area code:
  480-333-3764
  Not Applicable
  ______________________________________________
  Former name or former address, if changed since last report
  Check the appropriate box below if the Form 8-K filing is intended to
  simultaneously satisfy the filing obligation of the registrant under any
  of the following provisions:
  [  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
  [  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
  [  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  [  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
  Top of the Form
  Item 1.01 Entry into a Material Definitive Agreement.
  On March 8, 2006, the Company entered into employment agreements with Joan Sullivan Garrett to transition from Chief Executive Officer to Chairman, James E. Lara to continue acting as President and Chief Operating Officer, and James Allen Williams to take over as Chief Executive Officer.
  The Garrett Employment Agreement generally provides that Ms. Garrett will act as Chairman of the Company and be responsible for the representation and promotion of MedAire's brand to customers, governmental authorities, the medical community, and other stakeholders.  Ms. Garrett will further assist in formulating the strategic vision of the Company, but will not have any day-to-day management responsibility.  Ms. Garrett will retain all of the benefits and perquisites under her previous employment agreement, including an annual base salary of $249,690, an automobile allowance of $950 per month, and participation in the Company's benefit plans, including bonus, medical, dental and vision insurance, life insurance, long term disability insurance and the 401(k) plan.  The Garrett Employment Agreement will have a term of five years and will provide that Ms. Garrett's employment may not be terminated under any circumstances, but that the board of directors can elect to put Ms. Garrett on garden leave for the duration of the term of her employment, during which leave she will continue to be entitled to all pay, benefits and perquisites.  The Garrett Employment Agreement includes non-competition provisions which will end when the term of Ms. Garrett's employment ends.
  The Lara Employment Agreement generally provides that Mr. Lara will act as President and Chief Operating Officer of the Company.  Mr. Lara will retain all of the benefits and perquisites under his previous employment agreement, including an annual base salary of $216,300, an automobile allowance of $500 per month, and participation in the Company's benefit plans, including medical, dental and vision insurance, life insurance, long term disability insurance and the 401(k) plan.  The term of the Lara Employment Agreement runs through December 31, 2007 and is renewed automatically for additional one year periods, unless either party serves written notice of an intent not to renew at least six months before the end of the initial or any renewal term.  The Lara Employment Agreement may not be terminated under any circumstances, but the board of directors can elect, at any time, to place Mr. Lara on garden leave for 12 months with full pay, benefits and perquisites.  The Lara Employment Agreement includes non-competition provisions which will end two years after Mr. Lara's employment ends and confidentiality provisions that continue indefinitely.
  The Williams Employment Agreement generally provides that Mr. Williams will act as Chief Executive Officer of the Company and receive an annual base salary of $243,500, an automobile allowance of $500 per month, and participation in the Company's benefit plans, including medical, dental and vision insurance, life insurance, long term disability insurance and the 401(k) plan.  The term of the Williams Employment Agreement runs through December 31, 2007 and is renewed automatically for additional one year periods, unless either party serves written notice of an intent not to renew at least six months before the end of the initial or any renewal term.  The Williams Employment Agreement also includes a provision entitling the Company, at any time, to place Mr. Williams on garden leave for 12 months with full pay, benefits and perquisites.  The Williams Employment Agreement includes non-competition provisions which will end two years after Mr. Williams' employment ends and confidentiality provisions that continue indefinitely.
  Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.
  As previously disclosed, actions set forth in Consent Resolutions executed by shareholders holding the requisite number of outstanding shares of the voting stock of the Company necessary to approve such actions, which were included in a definitive Information Statement on Schedule 14C filed with the SEC and mailed to all shareholders of record on February 9, 2006, became effective March 1, 2006, 20 days from the date of such mailing.
  On March 8, 2006, the new Board of Directors of the Company elected pursuant to such Consent Resolutions held its first meeting,  received Joan Sullivan Garrett's resignation as Chief Executive Officer, designated Ms. Garrett to continue as Chairman of the Board pursuant to a new employment agreement, the terms of which are discussed under Item 1.01 above and incorporated by reference herein, and designated James Allen Williams to replace Ms. Garrett as Chief Executive Officer pursuant to a new employment agreement, the terms of which are discussed under Item 1.01 above and are incorporated by reference herein.
  Mr. Williams will continue as a member of the Company's Board of Directors, a position he has held since December 21, 2005.  Mr. Williams served as Executive Vice President and General Manager of International SOS Assistance, Inc. ("International SOS"), an emergency medical assistance company, from March 1999 through December 2004.  From December 2004 through October 2005, Mr. Williams served as President and Chief Operating Officer, Americas Region, of International SOS.  From October 2005 through December 2005, Mr. Williams served as Group Director for Health and Safety Market Development for International SOS.  Mr. Williams' corporate responsibilities for International SOS have included the consolidation of United States International SOS operations, building a professional management team, direct oversight of International SOS' operations in North, Central and South America and development of health and safety commercial strategy and capabilities for the oil and gas industries and the commercial and military aviation sectors.  Mr. Williams earned his Bachelor of Science degree in Mechanical Engineering from North Carolina State University.  Mr. Williams' business address is c/o International SOS Assistance Inc., 3600 Horizon Blvd., Suite 300, Trevose, Pennsylvania, 19053.
  Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
  As previously disclosed, actions set forth in Consent Resolutions executed by shareholders holding the requisite number of outstanding shares of the voting stock of the Company necessary to approve such actions, which were included in a definitive Information Statement on Schedule 14C filed with the SEC and mailed to all shareholders of record on February 9, 2006, became effective March 1, 2006, 20 days from the date of such mailing.
  The Consent Resolutions included a shareholder resolution asking the Board of Directors to consider amending Section 2 of Article II of the Company's Amended and Restated Bylaws to allow shareholders holding at least 10% of the Company's outstanding voting stock to call a special meeting of the shareholders (the "Bylaw Amendment").  At its meeting held on March 8, 2006, the Board of Directors considered and approved the Bylaw Amendment in the form attached hereto as Exhibit 99.1.  Prior to effectiveness of the Bylaw Amendment, shareholders did not have the right to call a special meeting of the shareholders.
  Item 8.01 Other Events.
  On March 10, 2006, the Company issued the press release attached hereto as Exhibit 99.2 and incorporated by reference herein summarizing the events described in this report.
  Item 9.01 Financial Statements and Exhibits.
  99.1  Bylaw Amendment Dated March 8, 2006
  99.2  Press Release Dated March 10, 2006
  Top of the Form
  SIGNATURES
  Pursuant to the requirements of the Securities Exchange Act of 1934, the
  	registrant has duly caused this report to be signed on its behalf by the
  	undersigned hereunto duly authorized.
  MedAire, Inc.
  March 10, 2006
  By:
  James Allen Williams
  Name: James Allen Williams
  Title: CEO
  Top of the Form
  Exhibit Index
  Exhibit No.
  Description
  99.1
  Bylaw Amendment Dated March 8, 2006
  99.2
  Press Release Dated March 10, 2006